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strains carrying integrons were signiﬁcantly more resistant to all tested antibiotics that strains lacking integrons. Five types of gene cassettes
belonging to class I integrons were identiﬁed in this study, and for the ﬁrst time two types of gene cassettes belonging to class II integrons are
reported. Most of the cassettes belong to a class I integron (136/144) encoding arr3, aacA4, dfrA17, aadA5, aadB, cat, blaOXA10, aadA1, aadA2,
dfrA and aacC1. Isolates contained a class I gene cassette; AadA2-HP-dfrA was the prevalent strain in this hospital. A class II integron was
detected in eight strains, which contained the type IV ﬁmbriae expression regulatory gene pilR and sulfate adenylyltransferase, suggesting a
possible role in multidrug resistance. The major epidemic strains from intensive care unit patients belong to international clone 2. In
conclusion, the presence of integrons was signiﬁcantly associated with multiple drug resistance of A. baumannii in this hospital, and class I
integron isolates bearing AadA2-HP-dfrA were the prevalent strain in this hospital.
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should be considered ﬁrst author.IntroductionAcinetobacter baumannii is an important cause of nosocomial
infection in intensive care units (ICUs) and is often resistant to
multiple antibiotics [1–3]. Integrons are partly responsible for
the multiantibiotic resistance of A. baumannii. Integrons are
genetic elements that can integrate, by site-speciﬁc recombi-
nation, antibiotic-resistant gene cassettes [4]. Five main types ofNew Microbes and New Infections © 2015 southwest university. Published by El
This is an open access artiintegrons have been described based the basis of the sequence
of the encoded 50 integrases (40–58% identity), including class I
(Tn402 derivatives), class II (Tn7 derivatives), class III (located
in a transposon), class IV (a subset of conjugative transposon in
Vibrio cholerae) and class V (located in a compound transposon
carried on a plasmid in Vibrio salmonicida) [5,6]. All the integrons
have a 50 conserved segment, including an intI gene encoding an
integrase and an attI recombination site, but have distinct 30
conserved segments. Gene cassettes from class I integrons
confer resistance to all known β-lactams, all aminoglycosides,
chloramphenicol, trimethoprim, streptothricin, rifampin,
erythromycin, fosfomycin, lincomycin and antiseptics of the
quaternary–ammonium compound family [7], while fewer
resistance cassettes (dfrA1, sat1, sat2, aadB, blaCARB-4, aadA1)
have been found that were associated with class II integrons [8].
In China, integrons containing drug-resistant cassettes were
considered to be a major resistant element [9,10], with an
integron detection ratio ranging from 52.3% to 69.6%.New Microbe and New Infect 2015; 8: 103–108
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and its colonization have greatly increased at the Second
Afﬁliated Hospital of Chongqing Medical University during the
last several years. The mechanism by which it is doing this needs
to be investigated. The aim of this study was to explore the
roles, characteristics and frequency of integrons in A. baumannii
drug resistance development at our hospital.Materials and MethodsTABLE 1. Primers for integron identiﬁcation
Integrase gene Primer sequence Reference
intl 1 50-GGCATCCAAGCAGCAAG-30 [12,13]
50-AAGCAGACTTGACCTGA-30
intl 2 50-ACCTTTTTGTCGCATATCCGTG-30 [14]
50-TACCTGTTCTGCCCGTATCT-30Isolates, antimicrobial agents susceptibility testing and
data analysis
Between January 2011 and December 2011, a total of 189
nonrepetitive clinical isolates of Acinetobacter baumannii were
collected from the laboratory of the Second Afﬁliated Hospital
of Chongqing Medical University. A. baumannii multidrug-
resistant isolates are resistant to more than two of the
following ﬁve drug classes: penicillins (piperacillin, ampicillin/
sulbactam or ticarcillin/clavulanic acid), cephalosporins (cefe-
pime, ceftriaxone, cefotaxime or ceftazidime), carbapenems
(imipenem), trimethoprim/sulfame–thoxazole, ﬂuoroquinolones
(ciproﬂoxacin, levoﬂoxacin or gatiﬂoxacin), and aminoglycosides
(gentamicin, tobramycin or amikacin) [11]. Minimum inhibitory
concentrations were determined by bioMérieux Vitek 2 AST-
GN 13 cards (http://www.biomerieux-diagnostics.com/vitek-2-
ast-cards) or MicroScan Dried Gram Negative Combo 31
panels (https://www.beckmancoulter.com/wsrportal/WSR/
diagnostics/clinical-products/microbiology/microscan-panels/
index.htm) with the relevant instruments. Our routine quality
control method was in accordance with the manufacturer’s
guidelines. The breakpoints of various antibiotics to A. baumannii
followed Clinical and Laboratory Standards Institute guidelines.
The susceptibility differences among A. baumannii strains were
analysed by the WHONET 5.6 program (World Health Orga-
nization; http://www.who.int/drugresistance/whonetsoftware/
en/). The chi-square test was used to determine the signiﬁ-
cance of differences. A difference was considered statistically
signiﬁcant if the p value was less than 0.05.
Integron detection
Primers for class I, II and III integrons identiﬁcation are listed in
Table 1. PCR ampliﬁcation parameters have been reported
previously [12]. One or two cassette amplicons representative
of each size were selected for DNA sequence characterization.
The resulting DNA sequences were analysed by the BLAST
program (http://www.ncbi.nlm.nih.gov/BLAST/).New Microbes and New Infections © 2015 southwest university. Published by Elsevier Ltd on beh
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(MLST) analysis of ICU strains
For the 33 strains from patients in the ICU, repetitive PCR
testing (rep-PCR) was carried out to analyse the endemic group
and additional sporadic isolates [15]. MLST analyses were
performed to characterize the epidemic features of ICU-
isolated strains [16]. The c scheme and protocols are publicly
available online (http://www.pasteur.fr/recherche/genopole/
PF8/mlst/Abaumannii.html).ResultsAntimicrobial susceptibility testing
The proportion of isolates resistant to tested antimicrobial
agents included piperacillin (92.7%), ampicillin/sulbactam
(84.5%), ticarcillin/clavulanic acid (80.4%), ceftazidime (88.7%),
ceftriaxone (90.2%), cefotaxime (92.2%), cefepime (93.8%),
imipenem (72.2%), amikacin (78.8%), gentamicin (81.4%),
tobramycin (76.8%), ciproﬂoxacin (89.7%), gatiﬂoxacin (62.6%),
levoﬂoxacin (67%) and trimethoprim/sulfame–thoxazole
(81.4%). The majority (93.3%) of the isolates in this study were
multidrug resistant (resistant to more than two categories of
antibiotic), which was higher than the reported ratio [17], and
38.7% of the isolates were resistant to all antibiotics used in our
test.
Integron assessment of A. baumannii isolates
Integrons were widely distributed among clinically isolated
A. baumannii strains in this teaching hospital in Chongqing,
China. Among the 189 isolates analysed by PCR, 144 isolates
(76.2%) were found to have the integron cassette; it was absent
in the rest. Among the integron-positive isolates, 136 had a
class I integron cassette and eight had a class II integron
cassette. We did not detect class III integrons in isolates from
this hospital.
Mapping of integrons
The cassette assortments in all the strains were characterized
by sequencing the ampliﬁcation products (Table 2). Among the
128 class I integron-carrying isolates, ﬁve different types of geneintl 3 50-GCCTCCGGCAGCGACTTTCAG-30 [14]
50-ACGGATCTGCCAAACCTGACT-30
alf of European Society of Clinical Microbiology and Infectious Diseases, NMNI, 8, 103–108
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TABLE 2. Integron cassette types and contents of
Acinetobacter baumannii clinical isolates
Integron
type
Coding
length
No. of
isolates Function annotation
Class I 1332 2 Arr-3 and aacA4
Class I 1606 2 DfrA17-aadA5
Class I 3124 2 AadB-cat-blaOXA10-aadA1
Class I 1998 135 AadA2-HP-dfrA
Class I 2513 11 aacC1-ORF1-ORF2- aadA1
Class II 480 5 Type 4 ﬁmbriae expression regulatory
protein, pilR
Class II 1480 4 Sulfate adenylyltransferase
dfrA12, dihydrofolate reductase; HP, hypothetical protein (HP); aadA2,
adenyltransferase; rifampin ADP-ribosylating transferase (arr-3) and aminoglycoside
60-N-acetyltransferase (aacA4) genes, aminoglycoside 20-O-adenylyltransferase
(aadB), chloramphenicol acetyltransferase (cat), oxacillinase (blaoxa-10), and
aminoglycoside 30- (9)-O-adenylyltransferase (aadA1) genes.
NMNI Huang et al. Integron characterization of A. baumannii 105cassettes in segments of approximately 1.3, 1.6, 2, 2.5 and 3.1
kb between the 50 conserved segment and the 30 conserved
segment regions were ampliﬁed by PCR. The ﬁve types of class I
integron cassettes included: aadA2-HP-dfrA, aacC1-ORF1-
ORF2-aadA1, arr-3-aacA4, dfrA17-aadA5 and aadB-cat-
blaOXA10-aadA1. The cassettes of aadA2-HP-dfrA accounted
for 83.9% of all integron-positive cassettes, making it was the
most prevalent type in the integron-carrying A. baumannii
isolate. There were two types of class II cassettes, comprising
type 4 ﬁmbriae expression regulatory protein pilR and sulfate
adenylyltransferase.
Correlation between integron and drug resistance
We compared susceptibility data from integron-positive and
-negative A. baumannii isolates (Table 3). The chi-square test was
used to calculate the p value in terms of resistant and suscep-
tible numbers of integron-positive and -negative isolates. Inte-
gron presence was signiﬁcantly associated with resistance to
certain antibiotics. The resistance ratio to amikacin, ampicillin/TABLE 3. Association between antibiotic proﬁle and integrons in A
Antibiotic
Antibiotic susceptibility Integron-positive
%R %I %S %R %I
AMK 78.6 2.3 19.1 91 0.8
SAM 84 4.8 11.2 92.4 2.1
SXT 81.3 0 18.7 91 0
CIP 89.3 1.1 9.6 95.8 0
GAT 61.8 23.1 15 68.4 25.6
PIP 92.5 3.5 4 97.7 0.8
GEN 81.3 3.2 15.5 91 2.1
TIM 79.8 7.5 12.7 85.7 9
FEP 93.6 1.6 4.8 96.5 1.4
CRO 89.8 7.5 12.7 96.5 2.1
CTX 91.9 5.8 2.3 97 1.5
CAZ 88.8 2.7 8.6 95.8 0.7
TOB 76.5 2.1 21.4 86.8 1.4
IPM 71.1 1.1 27.8 75.7 0.7
LVX 65.8 20.9 13.4 68.1 25.7
%R, resistant rate; %I, intermediate rate; %S, sensitive rate; AMK, amikacin; CAZ, ceftazidim
gatiﬂoxacin; GEN, gentamicin; IPM, imipenem; LVX, levoﬂoxacin; PIP, piperacillin; SAM, ampi
TOB, tobramycin.
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This is an open access artisulbactam, trimethoprim/sulfame–thoxazole, ciproﬂoxacin,
gatiﬂoxacin, piperacillin, gentamicin, ticarcillin/clavulanic acid,
cefepime, ceftriaxone, cefotaxime, ceftazidime, tobramycin,
imipenem and levoﬂoxacin were detected in integron-positive
A. baumannii strains than in integron-negative strains (p < 0.01).
Molecular typing of ICU-isolated strains
Because the ICU environment is the hardest hit with
A. baumannii infection, molecular typing using rep-PCR and
MLST were carried out in strains isolated from the ICU. Rep-
PCR testing of ICU isolates showed that 16 of 19 isolated
were closely related, with similarity scores of over 80% (Fig. 1).
We assumed that isolates with closely linked rep-PCR results
would be the same MLST type, so only ﬁve representative
strains were processed for MLST typing. All ﬁve strains were
consistent with sequence type (ST) 2, corresponding to Euro-
pean clone II [18].DiscussionAmong the 189 clinical isolates in our study, resistance ratios to
each tested antimicrobial agents were all above 60%. The sus-
ceptibility of clinical isolates to tobramycin (21.1%) and imipe-
nem (26.8%) is more that 20%; only these two antimicrobial
agents had a tolerable killing ability of clinical A. baumannii from
this hospital. These data highlighted the severe challenge of
drug-resistant A. baumannii nosocomial infection.
A total of 144 (76.2) of 189 strains were found to have an
integron cassette, most of them belonging to a class I integron.
The frequency of integron positivity in this hospital is higher
than that in other countries and regions, such as 60% in the
United Kingdom (A. baumannii) [19], 50% in the Netherlandscinetobacter baumannii strains
isolates Integron-negative isolates
p%S %R %I %S
8.3 35.7 7.1 57.1 <0.005
5.6 55.6 13.3 31.1 <0.005
9 46.7 0 53.3 <0.005
4.2 66.7 4.4 28.9 <0.005
6 40.5 14.3 45.2 <0.005
1.5 76.2 11.9 11.9 <0.005
6.9 46.7 6.7 46.7 <0.005
5.3 59.5 2.4 38.1 <0.005
2.1 84.4 2.2 13.3 <0.005
1.4 68.9 24.4 6.7 <0.005
1.5 76.2 19 4.8 <0.005
3.5 66.7 8.9 24.4 <0.005
11.8 40 4.4 55.6 <0.005
23.6 55.6 2.2 42.2 <0.01
6.2 45.7 10.4 43.9 <0.005
e; CIP, ciproﬂoxacin; CRO, ceftriaxone; CTX, cefotaxime; FEP, cefepime; GAT,
cillin/sulbactam; SXT, trimethoprim/sulfame–thoxazole; TIM, ticarcillin/clavulanic acid;
alf of European Society of Clinical Microbiology and Infectious Diseases, NMNI, 8, 103–108
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[21], 52% in Taiwan (Escherichia coli) [22], 43% in Europe
(Gram-negative isolates) [12], 41.5% in Brazil (Pseudomonas
aeruginosa) [23] and 52.8% in Nanjing [10] and 40.7% in Zhe-
jiang, China [24]. The class I integron-positive frequency (136/
189, 72.0%) is similar to those in Guangzhou, China (74.9%),
and Eastern China (69.6%) [9,25].
AdaA2-HP-dfrA is the most prevalent integron cassette in
our study. Recently a study in Southern China also revealed
dfrXII-orfF-aadA2 to be the major integron cassette [9]. DfrA is
a dihydrofolate reductase mediating the drug resistance to
trimethoprim, and AadA2 is a aminoglycoside adenyltransferase
involved in drug resistance to aminoglycoside. This integronFIG. 1. Repetitive PCR analysis of isolates from intensive care unit.
Isolates with more than 80% similarity were considered related. Arrow
indicates isolates processed by multilocus sequence typing analysis to
determine genotypes of Acinetobacter baumannii.
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Nanjing and Zhejiang [10,24], but the ratio of this cassette in
other regions is lower than our data. Other drug-resistant
genes were also present in these integron cassettes, including
aacC1, aadA1, arr3, aacA4, dfrA17 and aadA5; and aadB, cat and
blaOXA10 encoded resistance to aminoglycoside, rifampin,
sulfanilamide, chloramphenicol and β-lactam, respectively. Most
cassettes encoding various aminoglycoside resistance genes
were consistent with previous studies [22,26]. In addition, this
study detected only two sulfanilamide resistance genes (dfrA12
and dfrA17) and one β-lactam resistance gene (blaOXA10) in
A. baumannii integron, which seems insufﬁcient to explain the
signiﬁcant correlations between integron positivity and these
two types antimicrobial agents. Nearly all class I integrons
characterized to date contain a 30 conserved segment
comprising a sulI resistance gene in addition to the qacEΔ1 gene;
both of them mediated sulfanilamide resistance [27], and the
β-lactam-resistant genes might locate outside of integrons or
plasmids [12]. Integron positivity was also strongly correlated
with ﬂuoroquinolone resistance, although no ﬂuoroquinolone-
resistant genes existed in the integron. A previous study re-
ported a clear association of integron structures with mutator
plasmids, such as R46, in many Enterobacteriaceae [28], which
can confer an increased baseline mutation rate in the host cell
[29] and lead to an increase in the frequency of point mutations
that give rise to ﬂuoroquinolone-resistant phenotypes.
PilR is a member of the two-component regulatory system
PilS/PilR that regulates the expression of type 4 ﬁmbriae, which
was ﬁrst reported in Pseudomonas aeruginosa [30]. Type IV pili
are essential for motility, bioﬁlm formation, adherence to
multiple surfaces and natural transformation and virulence
[31,32]. In general, the drug-resistant characters of class II
integron-positive isolates and integron-negative isolates are not
signiﬁcantly different (except gatiﬂoxacin; data not shown), so
whether the two genes in the class II integrons are related to
drug resistance needs further study.
Isolates from the ICU belonged to the ST2 genotype in this
teaching hospital. The ST2 genotypic entity was also a pre-
dominated clonal lineage in multiple centers, such as Mediterra-
nean countries [33] and Germany [34]. In addition, ICU-isolated
strains also showed a relatively high carbapenem resistance (18 of
19 ICU isolates resistant to imipenem, for a resistance ratio of
95%; overall imipenem-resistant ratio is 71.1%), similar to that of
ST2 strains isolated from other countries [35,36].ConclusionThis study demonstrated the wide distribution of integrons
among A. baumannii within the Second Afﬁliated Hospital ofalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI, 8, 103–108
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feature of our ﬁndings is the prevalence of the major class I
integron consisting of aadA2-HP-dfrA resistance genes in this
hospital. Two novel class II integron cassettes also are reported.
Regardless of the presence or absence of resistance genes
within an integron, our data demonstrated a signiﬁcant associ-
ation between the presence of integrons and a reduced sus-
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